Skip to main content

Susana Boronat Guerero

Institutions of which they are part

Senior researcher
Genetics Medicine
Vall Hebron Institut de Recerca

Susana Boronat Guerero

Institutions of which they are part

Senior researcher
Genetics Medicine
Vall Hebron Institut de Recerca

Projects

Neurologia Pediàtrica (GRC)

IP: Alfons Macaya Ruíz
Collaborators: Susana Boronat Guerero, Francina Munell Casadesus, Maria Jose Pérez García, Miquel Raspall Chaure, Mireia del Toro Riera, Marta Vila Pueyo
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 1087
Duration: 01/01/2014 - 31/12/2016

Estudio multidimensional del espectro de los trastornos relacionados con la exposición prenatal al alcohol

IP: Miguel del Campo Casanelles
Collaborators: Núria Gómez Barros, Carlos Jacas Escarcellé, Susana Boronat Guerero, Anna Maria Cueto Gonzalez
Funding agency: Instituto de Salud Carlos III
Funding: 99220
Reference: PI12/02289
Duration: 01/01/2013 - 31/12/2015

Estada al Massachusetts General Hospital, Boston (EEUU)

IP: Susana Boronat Guerero
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 52000
Reference: BA11/00086
Duration: 07/11/2011 - 06/07/2013

Genes y migraña: clonaje posicional en migraña familiar y expresión en la depresión cortical propagada experimental

IP: Alfons Macaya Ruíz
Collaborators: Patricia Pozo Rosich, Susana Boronat Guerero, Miquel Raspall Chaure, Marta Vila Pueyo
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 90750.02
Reference: SAF2009-13182-C03-03
Duration: 01/01/2010 - 31/12/2012

Ministerio de Ciencia

Related news

The results show that, in some patients with mutations in the X chromosome, the healthy gene is inactivated and the mutated gene manifests itself, which favors the onset of the disease.

On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.

The research has studied the structure and function of proteins related to this degenerative disease and their interaction with SMN2 messenger RNA (mRNA), which is key to the evolution of patients.

Related professionals

Adria Aterido Ballonga

Adria Aterido Ballonga

Postdoctoral researcher
Rheumatology
Read more
Mònica Pons Delgado

Mònica Pons Delgado

Predoctoral researcher
Liver Diseases
Read more
Elena Granell  Pallares

Elena Granell Pallares

Administration and Management
Rheumatology
Read more
David Gurwitz

David Gurwitz

Senior researcher
Systemic Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.